Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin
نویسندگان
چکیده
Fig. 1. Cervical computed tomography (CT) images. (A) Cervical CT reveals right cervical lymphadenopathy. (B) Cervical enhanced CT reveals considerable improvement in right cervical lymphadenopathy after 3 cycles of chemotherapy with tetrahydropyranyl doxorubicin (50 mg on day 1), cyclophosphamide (750 mg on day 1), vincristine (1.6 mg on day 1), and prednisolone (50 mg on days 1–5). (C) Cervical CT reveals complete resolution of the right cervical lymphadenopathy at 6 months after clarithromycin add-on therapy. Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin
منابع مشابه
Bilateral myelomatous pleural effusion: presentation of two cases
monary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest 2010;138:730-3. 2. Ohe M, Hashino S. A case of follicular B-cell lymphoma treated using clarithromycin. Korean J Hematol 2011;46:203-6. 3. Ohe M, Hashino S, Hattori A. Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone. Korean J Hematol 2012;47:293-7. 4. Ohe ...
متن کاملA case of Waldenström’s macroglobulinemia treated using clarithromycin and prednisolone
Introduction Macrolides have been considered as potential antineoplastic and immunomodulatory agents. As antineoplastic agents, macrolides show anti-lymphoproliferative effects.[1] Various lymphoid malignancies, such as mucosa-associated lymphoid tissue (MALT) lymphoma,[2] follicular B-cell lymphoma,[3] diffuse large B-cell lymphoma,[4] Waldenström’s macroglobulinemia (WM),[5] multiple myeloma ...
متن کاملSuccessful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T-cell lymphoma characterized morphologically by lymphadenopathy with a polymorphic infiltrate, marked vascular and follicular dendritic cell proliferation. Patients usually present with advanced disease and the overall prognosis is poor. While intensive chemotherapy has been shown to induce complete remissions in 50-70% of patients, the...
متن کاملLong-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of aggressive non-Hodgkin lymphomas. Angioimmunoblastic T-cell lymphoma (AITL) is a common subtype of PTCL, and patients with AITL typically have a poor prognosis with limited treatment options. Clinical studies have demonstrated the activity of romidepsin, a structurally unique, potent, bicyclic class 1 selective histone deacetylase...
متن کاملRelapsed angioimmunoblastic T-cell lymphoma with acquired expression of CD20: a case report and review of the literature
BACKGROUND Angioimmunoblastic T-cell lymphoma is one of the most common types of peripheral T-cell lymphomas, usually presenting at an older age with an aggressive clinical course. Its characteristic morphological presentation and follicular helper T-cell phenotype help to distinguish it from other T-cell lymphomas. CASE PRESENTATION We recently encountered the unique case of a 63-year old pa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 51 شماره
صفحات -
تاریخ انتشار 2016